Monday, April 26, 2021

Cancer Diagnostics Market Overview, Dynamics, Growth Factors for Business Expansion, Key Companies, Trends and Forecast 2025

  Cancer Diagnostics Market-Overview

The prevalence of cancer cases in a broader section of society than before has paved the way for its development in terms of its treatment methods and diagnostics. Reports created by MRFR detail the developments of the industry that can be expected in the market through the forecast period. The global Cancer Diagnostics Market is estimated to rake in revenues of USD 163,000 Million with an 8.9% CAGR by 2025.

The late detection of cancer is a major cause for the fatality rates due to various cancer forms, and improvement in detection and diagnosis due to improvement in knowledge and technology is predicted to empower the cancer diagnostics market companies. Furthermore, advanced investments in the field of research are estimated to open up new options for progress in the cancer diagnostics market in the future.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1962

Segmental Analysis

The segmental evaluation of the cancer diagnostics market is conducted based on application, type, end-user, and region. The type segment of the cancer diagnostics market comprises of biopsy, biomarkers testing, imaging testing, in vitro diagnostic testing, and others. The application segment of the cancer diagnostics market comprises of prostate cancer, breast cancer, colorectal cancer, lung cancer, melanoma cancer, liver cancer, and others. The end-user segment of the cancer diagnostics market comprises of hospitals and clinics, research institutes, diagnostic centers, and others. The regions included in the cancer diagnostics market are the Americas, Europe, Asia Pacific, and other notable regions.

Detailed Regional Analysis 

The regional examination of the cancer diagnostics market covers regions such as the Americas, Europe, Asia Pacific, and other notable regions. The Americas cancer diagnostics market governed the global market due to the increasing elderly population, prepared healthcare sector, and growing healthcare spending in the region. The European cancer diagnostics market held the second main share of the worldwide market. The growing understanding of technological advancements in the region, cancer type, and symptoms, and the rising demand for effective medicine and diagnostics for cancer is anticipated to push the development of the regional market. The Asia Pacific regional market for cancer diagnostics is anticipated to list the speediest growth during the forecast period owing to the incidence of a large patient group and snowballing government proposals for the evolution of the region’s healthcare sector. The Middle Eastern & African regions are projected to hold the minimum portion of the cancer diagnostics market owing to the minimal economic development, particularly in the African region.

Competitive Analysis

The optimism about COVID-19 related treatment methods such as the vaccines being rolled out in various regions is estimated to further improve the overall sentiment in the market. The improvement in core industries performance on a global scale is estimated to fast track the development of the worldwide market in the upcoming period. The role of governmental bodies in facilitating the development of the market is estimated to be vital through the grant of special incentives to attract global titans to certain regions and contribute to the development of the market in the forecast period. Furthermore, the presence of better trade relations between several nations is estimated to offer more options for growth in the upcoming period. The overall development prospects of the market players are estimated to improve steadily with the effect of the COVID-19 pandemic reducing. The entry of global players in key developing regional markets is predicted to have a favorable effect that will ripple into other areas of the market as well.

The renowned players in the cancer diagnostics market are Arquer Diagnostics Ltd, QIAGEN N.V., Abbott Laboratories, Inc., BioMark Diagnostics Inc., Biotheranostics, Siemens Healthcare, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company (BD), Cancer Diagnostics, Inc., Exact Sciences Corporation, GE Healthcare, Roche Diagnostics, and Koninklijke Philips N.V., Inc.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/cancer-diagnostics-market-1962

Industry Updates:

Feb 2021 A research has been submitted that lifts the substantiation for using AI solutions in skin cancer diagnostics. By using an algorithm devised by them, the experts at the University of Gothenburg show the ability of technology to perform at a similar level as dermatologists in evaluating the seriousness of skin melanoma. Its purpose was by way of machine learning (ML), to direct an algorithm to control whether skin melanoma is aggressive and there is a danger of it persisting (metastatizing), or whether it stays at a growth phase in which it is limited to the epidermis, with no danger of metastasis.

Feb 2021 Google Cloud will incorporate its machine learning expertise into the cervical cancer diagnostic screening system of Hologic, a medical technology company. Hologic's cytology platform is the first to mix artificial intelligence with progressive digital imaging to determine cervical cancer cells and pre-cancerous lesions. Its alliance with Google Cloud announced lately, will grant the system to produce even more understandings from cytology slides. Google Cloud will also offer its secure cloud data architecture so the system can additionally develop its potentials.

Bladder Cancer Market Detailed Analysis, Growth Factors, Top Key Companies, Trends and Developments, 2018-2025

 

Market Research Future published a half cooked research report on “Global Bladder Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

 

The global market consist of players such as, Oncogenex (US), Astellas (Japan), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (UK), Accord Healthcare, Inc.(India), Pfizer (US), Novartis AG (Switzerland) Bristol-Myers Squibb company (US) and others. These are some of the major market players at the forefront of competition in the global bladder cancer market.

Global Bladder Cancer Market - Overview

The global market for bladder cancer is growing at a steady pace. This can be attributed to increasing prevalence of bladder cancer. It is reported that the exact cause of the bladder cancer is not clear, however, the medical condition is estimated to be aaocaited with certain factors which are inclusive mutations in the genetic composition of the patients, continuous exposure to harmful radiations, and adoption of unhealthy lifestyle. Such conditions are responsible for increasing the reported cases of bladder cancer across the globe. Moreover, factors such as increasing government support alongwith the growing investment in the research and development procees boosts the market growth. Adfditionally, rising awareness regarding the medical condition among the masses also contributs to the market growth. However, there factors such as high cost of the treatment in terms of expensive drugs, and related side effects are estimated to restarin the market tgrowth during the projected period.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1899 

Global Bladder Cancer Market - Competitive Analysis

The market for bladder cancer is well established market with number of companies operating in this market.

Bladder Cancer Market is expected to grow in the presence of increasing demands for better rtherapeutics. Currently, the market is witnissing an unavailability of absolute treatment. This can be seen as an for the market players to expand their market. The players, present in the global bladder cancer market are focusing on the development of new products. Such novel products are being designed with views of cost effectiveness and minimum side effects. Therefore, many companies in the market are involved in the development of specific types of molecules, and novel therapies have adopted the strategies of the acquisitions, product launches in order to strive in the competitive market. Additionally, competition amongst new entrants is expected to increase the growth for bladder cancer market over the forecasted period.

In October 2017, Astellas and Seattle Genetics initiated pivotal trial of Enfortumab Vedotin for patients with locally advanced or metastatic urothelial cancer.

In May 2017, AstraZeneca plc received U.S. FDA accelerated approval for the drug Imfinzi (durvalumab). This drug is intended to be used for previously treated patients with advanced bladder cancer.

In February 2017, Bristol-Myers Squibb received the FDA approval for Opdivo (nivolumab) in previously treated locally advanced or metastatic urothelial carcinoma, a type of bladder cancer.

In April 2017, FDA granted Roche’s atezolizumab, an accelerated approval as an initial treatment procedure for treating patients with advanced bladder cancer. It is the only immunotherapy paradigm approved for the treatment of advanced bladder cancer. 

In May 2017, Eli Lily & company announced results of their drug Cyramza’s phase III clinical trial for Bladder cancer. According to company reports, around 531 patients with urothelial carcinoma were treated in the trial, with a statistically significant improvement in progression-free survival. With this, Company received huge boost for the development of this drug in the treatment of bladder cancer.

In May 2017, FDA granted BAVENCIO (avelumab) approval for a common type of advanced bladder cancer.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/bladder-cancer-market-1899 

Global Bladder Cancer Market - Regional Analysis

On the basis of the geography, the global bladder cancer market is segmented into the four major regions, namely the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas holds the largest share in the global bladder cancer market. Presence of huge patient population suffering from bladder cancer is a major reason behind the same. As per the American Cancer Society, approximately 79,030 new cases of bladder cancer were reported in 2017. Moreover, it was estimated that the disease caused about 16,870 deaths withihn the U.S. Additionally, factors includfing changing lifestyle, rising government support, incrteasing role of cancer care organisations for incraesing the awareness s also impacts a positive growth in the global bladder cancer market.

Europe accounts for the second largest market share for the bladder cancer, which is followed by Asia Pacific. Asia Pacific is the fastest growing market owing to the huge population base, increasing prevalence of bladder cancer, rapidly developing economies and presence of huge opportunity for the growth of the market. The Middle East & Africa has the least market share due to the unavailability of the required healthcare infrastructure, lack of awareness among people.


LASIK Eye Surgery Market Size, Share, Trends and New Technologies Research Forecast to 2025

    LASIK Eye Surgery Market – Synopsis

Acknowledging the kind of growth the LASIK Eye Surgery market is witnessing currently and the growth prospects the market is demonstrating globally; Market Research Future (MRFR) recently published a brilliant study report giving out the complete market insights up till 2022. In its report MRFR asserts that the global LASIK Eye Surgery Market is projected to grow exponentially by 2022, registering 6.5% CAGR throughout the forecast period (2017 – 2022).

LASIK Eye Surgery also known as Myopia has gained a lot of recognition over the last few years owing to the ample benefits it offers along with the guaranteed success rate of almost 96%. Besides, this surgery promises chances to get rid of spectacles and contact lenses for life. Which is why many are opting to undergo this surgery to get their eye sight rectified. Resultantly, the market for LASIK Eye Surgery is garnering exponential traction on the global platform.

In addition, other factors that predominantly drive the market growth include growing population and urbanization that has introduced many devices like mobile phone and unhealthy lifestyle. Which resultantly has increased prevalence of myopia, hyperopia astigmatism and several other vision problems. To rectify these issues people are increasingly resolving to LASIK Surgery for its advantages.

Moreover, some LASIK companies work with insurance providers and certain large employers to provide LASIK discounts to their employees and CareCredit (a healthcare credit card) that covers all medical expenses, including LASIK eye surgery. These easy payment plans offered by LASIK companies fosters the market growth making LASIK as the most preferred surgery.

However, this revolutionary technique has a minor downside that is, its technical complexity. Which sometimes presents challenges to the doctors performing this surgery, while creating the flap. This can result in to damaging the vision permanently. But the good news is LASIK can rarely cause loss of “best” vision.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1774 

Worldwide LASIK Eye Surgery Market – Competitive Landscape

The market of LASIK Eye Surgery appears to be fiercely competitive & fragmented owing to the presence of numerous matured & small key players accounting for a substantial market share. These market players try to gain competitive advantage through strategic partnership, acquisition, expansion, collaboration, product & technology launch. They invest heavily in the R&D to develop a technology that is completely on a different level compared to their competition.

Industry, Innovation & Related News

February 27, 2018 – The LASIK Vision Institute (US), a leading provider of LASIK surgery, announced opening of a new center in Duluth, Georgia. The new facility will be featuring topography-guided LASIK technology, the latest in FDA-approved technology for this procedure.

February 14, 2018 – The Omaha Eye & Laser Institute (US) a Pioneer in LASIK & other Laser surgeries & of Eye Care announced that now the institute is also specialized in iLASIK (Customized Bladeless)  – considered as one of the most advanced forms of fully-customized , Lasik Laser Vision Correction

February 20, 2018 – Lehigh Valley Center (US) one of the leading eye care centre & LASIK Specialists announced the availability of IntraLase/Bladeless LASIK Eye Surgery.

Worldwide LASIK Eye Surgery Market – Segments

For an easy grasp and enhanced understanding; the report LASIK Eye Surgery Market is segmented in to 4 Key dynamics

By Vision Errors : Comprises – Hyperopia, Myopia, Astigmatism and other.

By Types            : Wavefront-guided, Wavefront optimized, topography guided and all lasers.

By End Users     : Hospitals, eye care clinic, LASIK center and other.

By Regions                 : North America, Europe, APAC and Rest of the World.

 

Access Report Details @  https://www.marketresearchfuture.com/reports/lasik-eye-surgery-market-1774

 

Worldwide LASIK Eye Surgery Market – Geographical Analysis

North America market dominates the global LASIK eye surgery market with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2016-2022).

Europe & Asia Pacific is the second & third largest market respectively in the global LASIK eye surgery market. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period.

Key Players:

Nidek, Inc., AMO Manufacturing USA LLC, Abbott Inc., Carl Zeiss, Inc., Alcon Laboratories, Inc., Lasersight Technologies. Inc. and Bausch & Lomb Surgical, Inc. are some of the leaders driving the Global LASIK Eye Surgery Market. Profiling those in its analysis MRFR finds out their strategies placing them at the forefront of completion.


Prostate Cancer Market to Reflect Impressive Growth Rate During 2017 to 2027

   Overview:

Prostate cancer is the occurrence of cancerous tumors in the prostate region of a man. The initial stage of the cancer remains within the prostate region where it is not expected to cause much harm. However, once it starts spreading it can turn fatal. The global Prostate Cancer Market is riding on the advantages provided by advanced technologies and could achieve substantial market growth during the forecast period (2018-2027). Market Research Future (MRFR) claims that the market could actually surpass the predicted valuation during the forecast period.

Factors like the introduction of advanced treatment procedures, better infrastructure & reimbursement policies, increasing awareness among people, better government initiatives can prove beneficial for the growth of the prostate cancer market.

Segmentation:

Product type and end-users are two segments that have been included by MRFR in their recent study of the global prostate cancer market. This segmentation takes the reader closer to factors and intake potentials for a better understanding of the growth curve of the market.

Based on the product type, the global prostate cancer market can be segmented into targeted therapies, therapeutic vaccines, hormone therapy and others. The targeted therapy segment is expecting high growth during the forecast period.

Based on the end-users, the prostate cancer market can be segmented into hospitals, clinics, and others. The hospitals segment is gaining better traction due to enhanced facilities for the treatment.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1580 

Regional Analysis:

Asia Pacific (APAC), Europe, the Americas, and the Middle East & Asia (MEA) are regions that have been included in the analysis of the global prostate cancer market report that has been studied by MRFR. This type of segmentation allows a better understanding of possibilities that various demography have to offer.

The market in the Americas is quite big as the combination of patient pool, better healthcare possibilities, and reimbursement policies is working quite well to pave the way for prostate cancer market expansion. Infrastructure in the region is quite superior and it is getting amply backed by high investment capacity. Mostly, it is North America that is generating profits for the market.

Europe’s growth is happening due to reasons that are quite similar to that of North America. Both regions have high awareness index and spend a substantial amount as funding for research and development sectors. At the same time, a number of companies are operating from the region, which is helping in generating revenues. Their nestling out in other emerging economies are also fetching in substantial market revenue.

The APAC region is expecting strong growth opportunities that would benefit them in generating revenues. Various factors like obese population, governments spending substantial amount to solidify healthcare sectors, various private initiatives, market titans showing great interest in the market, and rising disposable income are expected to promote the regional market. The region is riding on the back of countries like India, China, Japan, and Australia. The high ingress of advanced technologies is also proving beneficial for the regional market growth. Whereas the Middle East and Africa have low market due to his incapability of investment. The MEA region is slow in its growth but showing incredible signs of change as countries like Qatar, Kuwait, Saudi Arabia, Dubai, Oman, and others are spending substantially to improve their healthcare sector.

Browse Complete Toc :https://www.marketresearchfuture.com/press-release/prostate-cancer-market 

Competitive Landscape:

 A number of companies are making great contributions towards the global prostate cancer market. These companies are using strategic moves to alleviate their own strength and ensure a holistic market growth. These companies are Tokai Pharmaceuticals, Inc. Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Progenics Pharmaceuticals, Inc. (US), Endo Pharmaceuticals Inc., OncBioMune Pharmaceuticals Inc. (US), and others. MRFR considered these companies and profiled them in the report for a better analysis of the trend. 

In August 2019, researchers from the CSIR-Central Salt and Marine Chemicals Research Institute, Indiaannounced that the correct identification of Prostate Specific Antigen in blood can lead to an early diagnosis of the disease. In this, two compounds, spermine and spermidine can be used. To detect, they have developed cost-effective hybrid gel sensor that would seek the presence of the antigen.


Renal Dialysis Market Research Forecast, Regional, Trends and Analysis to 2025

  Overview:

Renal dialysis is a process that work as an alternative for affected kidney. The process maintains a semblance in the body by ensuring proper disposal of waste, salt, and excess water from the body. This is necessary to keep a safe level of various chemicals like potassium, sodium and bicarbonate in the blood flow. The global Renal Dialysis Market is all set to surpass USD 26.6 billion valuation with a CAGR of 7.1% over the forecast period of 2017 to 2023. Market Research Future (MRFR) has a report on the market that claims factors of the market would trigger ample growth for the market.

Factors impacting the global renal dialysis market includes hike in elderly population due to better treatment facilities, robust expenditure that the research & development sector is receiving, better probability of expansion with the hike in the healthcare sector investment. Transforming reimbursement policies to suit specific needs of patients can also improve market growth.

 

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1409 

Segmentation:

Market Research Future report on the renal dialysis market provides a comprehensive study of the renal dialysis market by setting a premise on the basis of types, product and end user. This segmentation has its focus on various factors that can impact the market in the coming years.

By type, the renal dialysis market comprises primary and secondary dialysis. Primary dialysis study encompasses hemofiltration, peritoneal dialysis, and hemodialysis. Secondary dialysis includes intestinal dialysis and hemodiafiltration.

By product, the renal dialysis market covers peritoneal dialysis products and hemodialysis products. The market is gaining ground by launching several new products in the hemodialysis products segment. The segment is expected to grab a higher market share in the foreseeable future.

Based on the end user, the renal dialysis market centers around home care and hospital care. It often becomes impossible to move patients much and sometimes, patients prefer home care for various reasons owing to which the home care has the advantage in better permeation.

Regional Analysis:

On a region-specific scale MRFR studied the global renal dialysis market by integrating regions like North America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). The study has substantial scope to unravel region-specific details and optimize potential as per the demand.

North America has better market reach and the region is finding superlative growth due to substantial inclusion of technologies and high expenditure capacity. The infrastructure of the regional healthcare sector is quite robust and is getting ample support from governments. The US and Canada are acting like crucial influencers.

Europe and Asia Pacific are also witnessing hike in the market revenue but the APAC market would achieve better market rate due to high impact from its massive population. The number of people suffering from kidney-related diseases is quite high. The MEA market would record a steady growth in the coming years owing to lack of takers in the African region. It would profit more from the Middle East part.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/renal-dialysis-market-1409 

Competitive Landscape:

A lot of companies are taking a substantial interest in the global renal dialysis market that can favor the holistic market growth. The process involves a lot of impact on the strategic moves that considers merger, acquisition, branding, marketing, and other aspects. MRFR acknowledged contributions made by these companies and have profiled them for the better understanding of the market growth. These companies are Fresenius Medical Care (German), Baxter International Inc. (US), B.Braun Melsungen AG (Germany), DaVita Healthcare Partners Inc. (US), Nipro diagnostic Inc. (US), Medical Care AG & Co., Gambro AB (Sweden), KGaA (Germany), Diaverum Deutschland GmbH (Germany), Nikkiso Co. Ltd. (Japan), Covidien (Ireland), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), and others.

In September 2019, Medtronic announced that their product IN.PACT Admiral DCB is showing favorable results in patients suffering from end-stage renal disease and who are having dialysis. Such a positive result would help it achieve FDA clearance

 

Breast Cancer Market: Growth, Demand and Key Players to 2025

 Overview:

The Global Breast Cancer Market is accruing and expected to gain further prominence over the forecast period mainly due to the growing prevalence of the disease, technological advancements and availability of effective treatments. According to a recent study report published by the Market Research Future, The Global Breast Cancer Market is projected to accrue at a rapid pace during the forecast period (2017 – 2023). The Market is forecasted to account for upsurge accretions by 2023with a staggering CAGR of 9.2% during 2017 and 2023. Brest cancer is a type of a cancer developed in breast tissue. Formation of lump in a breast, red patches on the skin are some of the common symptoms of the breast cancer. Obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are some of the risk factor for developing breast cancer.

Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1379 .

According to WHO, it is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and this number is continuously increasing. Prevalence of breast cancer is more common in developed countries compared to developing countries.

The Global Top Players for Breast Cancer Industry Mentioned are:

Pfizer (US), Novartis AG (Switzerland), Oncogenex (US), Apthera Inc. (UK), BioNumerik Pharmaceuticals (US), Oncothyreon Inc. (US), Astellas (Japan), Bipar Sciences (US), Puma Biotechnology (US), Sanofi S.A. (US), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (UK), Genentech (US), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (US), Bristol-Myers Squibb company (US), Actavis, Inc. (US), Hospira, Inc. (US), and Bayer AG (Germany).

Increasing number of females suffering from breast cancer is the major factor for the growth of market. Beside this adoption of unhealthy lifestyle, increasing female geriatric population, exposure to harmful radiation and increasing governmental initiatives also contributed in the growth of the market. As no absolute treatment is available there is a scope for developing the market across the world. While on other hand high cost of the treatment, adverse effects associated with the therapy and long approval time for the drugs are responsible for restraining the growth of the market.

Availability of more medicines, new screening tools gaining traction in breast cancer treatment. The biggest change has been the approvals for treatments and available screening tools. Over the last few years, advent breast cancer treatments have hit the market. So the biggest thing that’s emerged in the last year that’s really impacted the treatment is approval of medications called CDK45 Inhibitors. When used in combination with endocrine therapy for patients with hormone-receptor positive breast cancer, the medications have shown improvements in survival - about 10 months. In addition to promising medications, 3-D digital tomosynthesis imaging has gained traction and became available. Mammography allows for a more clear view of the inside of a breast. It’s particularly useful to see through dense breast tissue. A signed bill into law that allows commercial insurance providers to cover breast screening, including 3-D mammography.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/global-breast-cancer-market-1379

Breast Cancer Market – Competitive Analysis

Characterized by the presence of several major players, having international recognition; the global market of Breast Cancer appears to be highly fragmented and competitive. Marketers compete based upon price and brand reinforcement. Well established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage in this market and to maintain their market position.

Breast cancer is the most commonly occurring segment of cancer in women worldwide. The recent reports on cancer confirm the registration of 1.7 million cases of breast cancer. Women populace in the developed countries like U.S, U.K, and Australia are more prone to the breast cancer than in the developing countries. Factors such as lifestyle, age, heredity and also genetic mutations (abnormal changes) are responsible for developing a breast cancer. The high incidence rate worldwide is becoming a major concern and the pharmaceutical companies are increasingly investing in research on breast cancer.

Breast Cancer Market – Segments

The Breast Cancer Market is segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;

Segmentation by Types: Comprises Invasive Ductal Carcinoma, Invasive Lobular Carcinoma and other.

Segmentation by Treatment : Comprises Chemotherapy (Antimetabolites, Anthracyclines, Taxanes & Alkylating Agents), Surgery & Radiation Therapy, Targeted Therapy (Tyrosine Kinase Inhibitors &Monoclonal Antibodies), Biologic Therapy, Hormone Therapy (selective estrogen-receptor modulators (SERMs), aromatase inhibitors) and other.

Segmentation by End Users: Comprises Hospital Pharmacies, Private Pharmacies and others.

Segmentation by Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Chemotherapy accounts for the largest share of the market; i.e. 45%.

Breast Cancer Market – Regional Analysis

On regional basis, global breast cancer market is dominated by America. Changing lifestyle and increasing prevalence of breast cancer in America has driven the growth of the market. America breast cancer market is followed by Europe. Technological advances, increased life expectancy and healthcare expenditure of people is responsible for the growth of this market in America and Europe. Asia Pacific is expecting a fastest growth for the market.

Major TOC for Breast Cancer Market Research Report - Global Forecast To 2023:

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

Ask To Expertise @ https://www.marketresearchfuture.com/enquiry/1379

Optogenetic Market: Market Opportunities, Competitive Landscape, Segmentation, Analysis & Forecast 2025

   Market Research Future published a Half Cooked research report on “Global Optogenetic Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Optogenetic market-Overview

The field of neuroscience has evolved from last few years due to number of studies done on neurons and other cells in the body. Optogenetics is a biological technique that involves the use of light to control cells in tissues such as the neurons. These cells are genetically modified to express light-sensitive ion channels. It combines methods from optics and genetics. It is used for the monitoring of neurons. There are various products in optogenetics available in the market such as light instruments used, actuators, and sensors.

Optogeneticcs has evolved from last few years with an aim for determining the development of neural circuits. The optogenetic sensors are now being successfully used for studying various phenomenon in neuroscience and enhance the capabilities in the field of neuroscience. The green fluorescent protein (GFP) technique, that has brought a revolutionized change in the field of scientific research and is a part of optogenetics.

Increasing use of growing use of the tool in the field of neuroscience and behavioural science, rapid advancement in technology such as ultrafast laser tools, LEDs, ytterbium-based lasers and others, as well as the increasing number of labs worldwide that have adopted the advanced technology for research. High cost of technology, lack of awareness of the tools in developing countries, reluctance in adoption of new technology by healthcare professionals restrain the growth of the market.

Americas acquire the largest market share in the optogenetics market. The growth of the market is attributed to an increasing research in neuroscience and availability of funds for research and development activities in the U.S. and other American countries. Additionally, the market is shows rapid growth due to the technologies available of cell modifications and other processes in cell biology. Increasing number of research institutes and academic centres as drive the growth of the market.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1307

Key players in the Optogenetic market:

The global optogenetic market is highly fragmented with the presence of many local players and international players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

Some of the key players operating for the global optogenetic are Coherent Inc. (U.S.), Thorlabs Inc. (U.S.), Laserglow technologies (Canada), Regenxbio Inc. (U.S.), Addgene (U.S.), UPenn Vector Core (U.S.), Jackson Laboratories. (U.S.), Cobalt International Energy, Inc. (U.S.) and others.

Key developments and strategies for key players in optogenetic market:

Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players. The key players are engaged in determining new methods and technology that can be applied in the field of neuroscience. Additionally, the market is also driven by key players concentrating on key players in the market. Thorabs Inc., Regenxbio Inc., and Jackson Laboratories are key players that focus of agreement as well as research activities in neuroscience.

Addgene:

Addgene is a global, non-profit plasmid repository dedicated in preparing the useful resources for scientists and researchers. The resources offered by the company are useful for the studies in neuroscience.

Thorlabs Inc.:

  • June, 2017: Thorlabs and greenTEG Switzerland-based entered into an agreement to integratie and distribute thermal sensors in the photonics market. As a part of the agreement, Thorlabs will develop a comprehensive Origincal equipment Manufacturer (OEM) strategy for the resale of greenTEG’s thermal sensors in the photonics market segment.

Regenxbio Inc.:

  • June, 2017: Regenxbio Inc. announced worldwide license agreement for AveXis for the development and commercialization of gene therapy treatments using REGENXBIO’s NAV AAV9 vector for treatment two rare neurological monogenic disorders.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/optogenetics-market-1307

Jackson Laboratories:

  • June, 2017: Jackson Laboratories announced worldwide preclinical research agreement with Crown Bioscience. The agreement focuses on a global technology platform for Oncology, and Cardiovascular and Metabolic Disease. The agreement will result into an acceleration of to accelerate the rate of pre-clinical research and discovery. The company looks forward to expand in China through strategic clinical genomics research agreement with three groups in China. The collaboration will provide thus, the company will be able to gain access to the clinical expertise of the medical university and its affiliated hospitals.

Contrast Media Market Analysis, Market Status, Competition & Companies, Growth Opportunities, Top Key Players and Forecast by 2025

  Market Synopsis

The analysis conducted by Market Research Future (MRFR) has revealed that the global Contrast Media Market is estimated to record a CAGR of 3.5%, holding a substantial market value during the forecast period. The growing chronic illness, such as cancer, cardiac diseases, along with the accidental cases, is likely to drive the global media market 2020. Their application in medical imaging to increase the visibility of blood vessels and the GI tract is anticipated to further fuel the global market. In addition, the demand for better diagnostic imaging services and diagnostic imaging modalities have produced lucrative opportunities, which are likely to grow the market substantially in the forthcoming period.

On the contrary, the harmful aftermath of contrast media is likely to restrict market growth. However, technical development, along with the aforementioned factors are likely to fight the hampering market.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1044

Market Segmentation

The segment analysis of the global contrast media market is done by form, type, application, procedures, and route of administration.

The form based segments of the global contrast media market are powder, tablet, liquid, and paste.

The type based segments of the global contrast media market are gadolinium-based contrast media, iodinated contrast media, microbubble contrast media, and barium-based contrast media.

The application based segments of the global contrast media market are neurological disorders, oncology, cardiovascular disease, gastrointestinal disorders, and other indications.

The procedures based segments of the global contrast media market are magnetic resonance imaging (MRI), X-ray/computed tomography (CT), ultrasound, and others.

The route of administration based segments of the global contrast media market is oral, rectal, and injectable.

Regional Analysis

Based on the region, the global contrast media market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). As per the analysis, the global market is projected to be dominated by North America on account of fast developing technical advancement in the field of medical and imaging. Further, the presence of established key players in the region is likely to play a crucial role in developing the regional market. Also, the increasing prevalence of chronic ailments, usage of advanced technologies for the diagnosis of diseases is estimated to drive the regional market efficiently.

Europe is likely to acquire the second position in the global contrast media market owing to the increased healthcare expenditure and the usage of advanced technologies. Further, the increased medical supplies market in the region is estimated to be another crucial factor in stimulating the regional market. Besides, the presence of key players in the region is projected to be another crucial reason for regional development.

The APAC region is estimated to be a lucrative market owing to the developing healthcare sectors. Further, the presence of developing countries in the region is shooting the regional market. Besides, the crucial participation of the fastest developing economies of the world, such as India, Japan, and China, are likely to develop the market significantly. In addition, the increasing awareness of functionalities of contrast media is estimated to drive the market substantially.

The MEA is estimated to acquire the least market share owing to the presence of poor economies. However, increasing awareness about health is estimated to boost the regional market in the forthcoming period.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/contrast-media-market-1284

Key Players

NANOSCAN IMAGING (US), DAIICHI (Japan), Bayer AG (Germany), GE Healthcare (US), Bracco Diagnostic Inc. (US), Guerbet Group (France), Spago Nanomedical AB (Germany), Lantheus Medical Imaging Inc. (US), Jodas Expoim (India), Magnus Health (US), and Taejoon Pharm (Korea) are some of the known players in the global contrast media market.

Growth of Contraceptive Drugs Market Projected to Amplify During 2017-2025

   Market Analysis

The global Contraceptive Drugs Market is expected to touch new high of around USD 22.15 billion at a splendid 6.5% CAGR during the forecast period (2018-2023). Simply put, contraceptive drugs or pills are medicines that help in preventing unwanted pregnancy. It will block the usual ovulation process or alter the process that supports the egg’s fertilization. Patches, combined oral contraceptives, implants, injectables, vaginal rings and intra-uterine devices (IUDs) are the most recent contraceptive methods that is accessible in the market.

There are numerous factors that is driving the contraceptive drugs market. Some of the market factors and trends in this market as per a study conducted by Market Research Future (MRFR) include increase in the existence of sexually transmitted diseases, increasing focus on the advancements in technology, rise in the initiatives taken by governments and NGOs for promoting the use of contraceptive drugs, increasing innovations and research activities in this field, rising use of contraception drugs in young women, increase in higher education attainment, increase in the intake of oral pills and awareness about modern contraception. On the contrary, factors such as strict governmental rules in most of the countries, side effects associated with contraceptive drugs, religious and cultural opposition of such drugs in developing countries and also the rising prevalence of infertility is projected to restrict the growth of the contraceptive drugs market in the coming years.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1276 

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the contraceptive drugs market on the basis of type and end-user.

Based on type, it is segmented into injectable, oral contraceptive and others. The oral contraceptive segment is further segmented into progestogen-only pills and oral contraceptive pills. Of these, the oral contraceptives segment is expected to have the maximum share in the contraceptive drugs market during the forecast period due to widespread utilization of oral pills by women.

Based on end user, the contraceptive drugs market is segmented into hospitals, clinics and others.

Competitive Analysis:

Leading players in the global contraceptive drugs market include Cooper Surgical, Mayer Laboratories, The Female Health Company, Church & Dwight, Reckitt Benckiser plc, Piramal Enterprises ltd., Mankind Pharma Ltd., Janssen Global Services LLC, Allergan plc, Bayer AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and Merck & Co., Inc.

In August 2019, 536 oral contraceptive drugs were switched from the class of prescription drugs to over the counter products in the Indian city of Hyderabad. This is likely to be a rising trend in the contraceptive drugs market over the forecast period, as more prescription contractive drugs get switched to OTP status all over the world. The rising awareness about the side effects of contraceptive drugs has led to this move, as consumers are now aware of the side effects and don’t need a consultation with a doctor to finalize their purchase.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/contraceptive-drugs-market-1276 

Regional Analysis

Based on region, the contraceptive drugs market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will command the market due to rising awareness amid people coupled with increase in the rates of abortion. As per the 2015 report published by the Centers for Disease Control and Prevention, approximately 229,715 babies had been born from females aged 15-19 years. Europe also has a favourable share in the contraceptive drugs market due to increasing awareness regarding healthcare industries, well-developed technology and increasing government support. Besides, companies here are mostly into export that will boost up the share of the market across the globe. The APAC and the Middle East and Africa are also likely to have a favorable share. Countries such as China and India will experience the fastest growth in the contraceptive drugs market owing to increasing incidence of pregnancy amid teenagers. As per WHO, the birth rates in adolescents is 45 births/1000 females in South-Eastern Asia while 7 births/1000 females in Eastern Asia. They are open for adopting new treatment choices from developed countries. It is this gap amid the developed countries and the developing countries that will offer growth opportunities for the market players in the near future.

Key Players

Leading players profiled in the contraceptive drugs market include Cooper Surgical (US), Mayer Laboratories (US), The Female Health Company (US), Church & Dwight (US), Reckitt Benckiser Plc (UK), Piramal Enterprises Ltd (India), Mankind Pharma Ltd. (India), Janssen Global Services llc. (US), Allergan plc. (Ireland), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc (US) and Merck & Co., Inc (US),

Jan 2019- A research conducted by a postdoctoral researcher, Wei Li at Atlanta’s Georgia Institute has introduced an innovative technology which will offer the contraceptive levonorgestrel with the help of a microneedle skin patch. This patch will come with drug-containing needles which will break off post application of the patch for a couple of seconds. This tiny needle will remain under the skin and release the drug. The new technology will allow women in self-administering the long-acting contraceptives within seconds.


Expansion of Post-Operative Pain Management Market to Remain Consistent During 2017-2025

   Overview:

Global Post-Operative Pain Management Market was expected to grow at a CAGR of 5.4% during forecasted period 2017-2023.

Post-operative pain management is the most important part of the patient treatment as it helps in providing patient comfort, lessens the possibility of pulmonary, cardiac and neuropathic pain complications and also helps in minimizing the cost of hospital stay. This treatment mostly consist of analgesic treatment that act on various mechanism and minimize the pain. Increasing number of surgeries and rising demand for the pain management treatment is the major reason for the growth of the market. Analgesics are habit forming drugs and can also damage the renal system, this is the major restraining factor for the market.

According to cancer research UK, in 2012, globally over 14.1 million of new cancer cases were registered. The treatment for the all types of cancer are nearly similar, thus increasing prevalence of cancer has boosted the development of the new treatments.

According to Migraine Research Foundation, (2014), migraine was the 3rd most prevalent illness in the world. Nearly 1 in 4 U.S. households includes someone with migraine. Moreover, 12% of the population including children have migraine problem. 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1246 

Global Post-operative Pain Management Market  – Competitive Analysis

Many of the top companies are launching new and novel drug treatment to increase their market. Because of side effect and habit forming property of the therapy major players are concentrating on development of better analgesic. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Teva Pharmaceutical Industries Ltd. is the Israeli multinational pharmaceutical company working in the development and manufacturing of the drugs. Celecoxib intravenous is the major products of the company. Company has signed a collaborative agreement with Regeneron for the development of fasinumab which is a pain management drug. In first quarter of 2017 company has accounted a revenue of $ 5.6 billion. In 2014, company has acquired Labrys Biologics. This acquisition will help to achieve its goal of becoming a global leader in pain drugs by 2020.

Novartis, one of the leading pharmaceutical companies headquartered in Switzerland. In Nov 2016, company has plan a phase II trial for the NCT02961062 in the treatment of postoperative pain. They have almost completed the trials for the SAF312 in postoperative dental pain patients and company is expecting to launch the product soon. In May 2017, Novartis has sign a deal of $ 293 million with Durect for pain killer Posimir.

Pfizer Inc. a world’s largest American pharmaceutical companies headquartered in US. Parecoxib is the widely used drug of this company. Due to Lyrica which is a pain treatment the net income of the company has increased by 13 % in 2016. Company has completed the clinical trials for the EMBEDA for the post-operative pain management.

Forest Laboratories which is the American Pharmaceutical company headquartered in US. Forest Laboratories and Trevena Inc. has announce Collaboration for development of TRV027 which is used in the post-operative pain treatment.

Browse Full Report @ https://www.marketresearchfuture.com/reports/post-operative-pain-management-market-1246

Global Post-operative Pain Management Market  – Regional Analysis

Geographically, America accounts the largest share for global post-operative pain management market owing to increasing number of surgeries and rising burden of chronic diseases has led to the growth of this market in America. Europe is the second largest post-operative pain management market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. Asia Pacific is the fastest growing region for the market due to increasing prevalence of many diseases, increasing aging population and development in healthcare infrastructure in this region has provided fuel for the growth of the market. The Middle East dominates the Middle East & Africa market due to the presence of well developed countries like Kuwait, Qatar, Oman and South Arabia. Whereas, Africa region is expecting a healthy growth due to presence of huge opportunity for the development of the market.

Key Players:

Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly Company (U.S), Pfizer (U.S), Johnson & Johnson (U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Valeant Pharmaceuticals International Inc. (Canada) are some of the prominent players at the forefront of competition in the Global Post-operative Pain Management Market and are profiled in MRFR Analysis.

Friday, April 23, 2021

Surgical Stents Market: Growth Factors Details for Business Development, Key Companies, Current Trends/Issues/Challenges and Forecast By 2025

   Market Analysis 

The global Surgical Stents Market is likely to grow at a 7.9% CAGR between 2017- 2023, as per the Market Research Future’s (MRFR) new report. Surgical stents, simply put, are small tube like medical devices that are placed into arteries or blood vessels for opening blockages in vessels. Primarily, stents are used to treat renal and cardiac diseases. Esophageal stents, urinary stents, prostatic stents, biliary stents, cardiac stents, and others are the different types of surgical segments. It is made of different materials such as a standard polymer, biodegradable polymer, and metal. Some of its key applications include urinary tract disease, cardiac disease, and others.

Numerous factors are adding to the global surgical stents market growth. Such factors, according to the new MRFR report, include rising adoption of a sedentary lifestyle, growing consumption of suboptimal diet, increasing adoption of minimally invasive techniques, and the growing number of minimally invasive surgeries. Additional factors adding market growth include changing lifestyle, increasing geriatric population, rising healthcare expenditure, rapid technological advancements, increasing obese and diabetic population, and increasing cases of cardiovascular diseases.

On the contrary, product recalls owing to safety issues, complications & risk of infection related to stent implantation, and higher surgery cost are factors that may limit the global surgical stents market growth over the forecast period.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1044

Market Segmentation 

The MRFR report offers an inclusive segmental analysis of the global surgical stents market report based on application, end users, types, and type of materials.

By types, the global surgical stents market is segmented into esophageal stents, urinary stents, prostatic stents, biliary stents, cardiac stents, and others. Cardiac stents are again segmented into artery stents, bio-engineered stents, drug eluting stents, balloon expanding stents, self-expanding stents, dual therapy stents, and others. Urinary stents are again segmented into closed end stents, open end stents, multi loop stents, and double pigtail stents.

By metal, the global surgical stents market is segmented into standard polymer, biodegradable polymer, and metal. Of these, the metal segment will lead the market over the forecast period for its various benefits, such as biocompatibility and enhanced flexibility.

By applications, the global stents market is segmented into urinary tract disease, cardiac disease, and others.

By end users, the global stents market is segmented into hospitals, clinics, & others. Among these, hospitals will have a major share in the market over the forecast period.

Regional Analysis

Based on the region, the surgical stents market report covers the recent trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. Higher healthcare expenditure, presence of well-developed healthcare sector in the region, and rising prevalence of renal & cardiac diseases are adding to the growth of the market in the region.

The surgical stents market in Europe is predicted to hold the second-largest share over the forecast period, followed by the Asia Pacific. Factors adding to the surgical stents market in the region include rapidly developing economies, huge patient population, rising prevalence of cardiovascular disorders, favorable government initiatives, and effective strategies undertaken by the government.

The surgical stents market in the RoW is predicted to have sound growth over the forecast period.

 Browse Complete Toc :https://www.marketresearchfuture.com/reports/surgical-stents-market-1044 

Key Players 

Eminent players profiled in the global surgical stents market report include Elixir Medical Corporation (US), Boston Scientific Corporation (US), STI Laser Industries, Ltd (Israel), B. Braun Melsungen AG (Germany), Laserage Technology Corporation (US), Medtronic (US), Amaranth Medical, Inc (US), amg International GmbH (Germany), ELLA – CS, s.r.o. (Czech Republic), Arterial Remodeling Technologies (US), Meril Life Sciences Pvt. Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), and Angiocare (Netherlands).

 
 

Big Data in Healthcare Market Detailed Analysis, Growth Factors, Top Key Companies, Trends and Developments, 2018-2025

  Market Synopsis

Market Research Future (MRFR) asserts that the global Big Data in Healthcare Market is expected to acquire a market value of USD 17,278.13 million while thriving at a CAGR of 20.69% during the forecast period 2015 to 2022.

The increasing demand for analytics solutions for the health management of the expanding populace is expected to be a significant factor that can propel the healthcare big data analytics market. The growing adoption of mobile health apps and IoT is likely to emphasize the need to manage an enormous amount of data to procure important information, which can augment the market during the assessment period. Furthermore, the surging demand to curb healthcare costs and on-going advancement in the healthcare sector is expected to drive the healthcare big data analytics market.

On the flip side, lack of privacy of the confidential medical records is expected to hinder the market growth during the forecast period. However, advanced real-time care and reduced medication errors are expected to counter the impeding factor that can grow the healthcare big data analytics market.

 Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/791 

Market Segmentation

The segmental analysis of the global big data in healthcare market is done by components and services.

The components-based segments of the global big data in healthcare market are hardware and software types. The hardware segment is further segmented into virtual private network (VPN), routers firewalls, email servers, data storage (storage on-premise/ data centers/storage on-demand/storage on-cloud), and wireless & access points. The software segment is further segmented into practice management software, electronic health record (EHR) software, workforce management software, revenue cycle management software, and others.

The service-based segments of the global big data in healthcare market are financial analytics, clinical data analytics, and operational analytics. The clinical data analytics is further segmented into quality care, reporting, precision health, population health management, clinical decision support, and compliance. The financial analytics is segmented into claims processing, management, revenue cycle, and risk assessment. The operational analytics is segmented into supply chain analytics and workforce analytics.

Browse Complete Toc : https://www.marketresearchfuture.com/reports/big-data-healthcare-market-791 

Regional Analysis

Based on the region, the global market for the big data in healthcare is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.

According to the research conducted by MRFR, the global market is anticipated to be dominated by the Americas. The region is expected to procure a considerable portion of the market share owing to the growing expenditure on healthcare. The presence of prominent key players in the region is anticipated to grow the region significantly.

Europe is likely to acquire a second position owing to the growing expenditure on health during the forecast period. The demand to curb the rising healthcare costs is expected to be another salient cause that can augment the regional market during the review period.

APAC is likely to be the fastest-growing market during the forecast period owing to the increasing trails and growing geriatric population. Emerging nations, such as India and China, are likely to play a crucial role by developing the healthcare infrastructure.

MEA is anticipated to be majorly driven by the Middle East countries; such as, Saudi Arabia and the UAE, due to economic stability. The African region is likely to witness sluggish growth due to poor economic conditions and underdeveloped healthcare infrastructure. However, there are various untapped opportunities that can aid in uplifting the regional market.

Key Players

Renowned players of the global big data in healthcare market are Cognizant, Dell, Cerner Corporation, GE Healthcare, Optum, Philips, Mckesson, Siemens, Xerox, and others.